MiniMed 670GRecalls & reported problems across all models

We found 23 models of MiniMed 670G by Medtronic Minimed, Inc. in the FDA's device registry (GUDID). Together they are named in 141,169 adverse event reports in the FDA's MAUDE database, received between Jun 2, 2017 and Sep 19, 2025 — classified as 197 deaths, 35,304 injuries, 105,668 malfunctions.

The most frequently reported specific device problem is “Patient Device Interaction Problem” (43,315 reports).

4 FDA recall records name at least one of these models by its device identifier, 4 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works

MiniMed 670G recalls

FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.

1. Feb 13, 2026Open, Classified

   All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.

   Z-1739-2026 · Root cause: Device Design · names 18 of these models · Recall details · FDA record ↗

2. Jul 31, 2024Open, Classified

   Insulin pumps that have been dropped, bumped, or experienced physical impact may have damage to internal electrical components, which may cause reduced pump battery life. Since the defect reduces the battery life overall, it shortens the time between low battery alarms and increases the frequency with which the user must insert a new battery. Further, the defect may also deliver the low battery alarm when there is significantly less time before the battery completely runs out, from the expected up to 10-hour buffer the low alert is supposed to signal, leading to device powering down and stopping insulin delivery unexpectedly. Per the firm, a subset of pumps with the defect showed the low alert alarm was delivered ~2.5 hours before the device shut off, however, patient reports indicate the time could be even shorter. Replacing the battery will not resolve this issue and the short battery life and the truncated low battery alert lead time will continue to occur. Early battery depletion could result in power loss and insulin delivery could be interrupted, resulting in under delivery of insulin potentially leading to hyperglycemia and/or DKA.

   Z-0003-2025 · Root cause: Device Design · names 22 of these models · Recall details · FDA record ↗

3. Sep 20, 2022Open, Classified

   Medtronic identified a cybersecurity vulnerability in the MiniMed 600 series Insulin Pump Systems associated with the communication protocol that could allow unauthorized access to the pump system. This unauthorized access could be used to deliver too much or too little insulin through delivery of an unintended insulin bolus or because insulin delivery is slowed or stopped, which could lead to hypoglycemia or hyperglycemia. The Remote Bolus feature on insulin pumps should be turned off to prevent the unauthorized access.

   Z-0193-2023 · Root cause: Component change control · names 8 of these models · Recall details · FDA record ↗

4. May 23, 2022Open, Classified

   Due to battery cap deterioration, this may potentially result in an incomplete battery circuit (similar to when battery cap is not attached) and a loss of power/functionality of the insulin infusion pumps.

   Z-1355-2022 · Root cause: Device Design · names 10 of these models · Recall details · FDA record ↗

Most reported MiniMed 670G problems

MiniMed 670G models

23 models, most reported first. Each model has its own page with its reports, recalls and device details.

• MiniMed® 670G MMT-1780KPK

  Artificial pancreas device system, single hormonal control
  3 recalls78 deaths55,723 reports
• MiniMed® 670G MMT-1780KPK

  Automated insulin dosing device system, single hormonal control
  2 recalls51 deaths33,713 reports
• MiniMed®670G MMT-1780KPK

  Artificial pancreas device system, single hormonal control
  3 recalls39 deaths28,789 reports
• MiniMed® 670G MMT-1780KL

  Automated insulin dosing device system, single hormonal control
  3 recalls8 deaths8,353 reports
• MiniMed® 670G MMT-1780K

  Artificial pancreas device system, single hormonal control
  3 recalls7 deaths6,776 reports
• MiniMed® 670G MMT-1780KPK

  Automated insulin dosing device system, single hormonal control
  3 recalls10 deaths4,325 reports
• MiniMed® 670G MMT-1780KL

  Artificial pancreas device system, single hormonal control
  3 recalls1 death958 reports
• MiniMed® 670G MMT-1780KL

  Automated insulin dosing device system, single hormonal control
  3 recalls2 deaths783 reports
• MiniMed® 670G MMT-1780KL

  Automated insulin dosing device system, single hormonal control
  2 recalls1 death823 reports
• MiniMed® 670G MMT-1780KL

  Automated insulin dosing device system, single hormonal control
  2 recalls374 reports
• MiniMed® 670G MMT-1760KPK

  Automated insulin dosing , threshold suspend
  2 recalls303 reports
• MiniMed® 670G MMT-1780KL

  Automated insulin dosing device system, single hormonal control
  3 recalls95 reports
• MiniMed®670G MMT-1760KPK

  Automated insulin dosing , threshold suspend
  3 recalls82 reports
• MiniMed® 670G MMT-1760KPK

  Automated insulin dosing device system, single hormonal control
  3 recalls38 reports
• MiniMed® 670G MMT-1760KPK

  Artificial pancreas device system, single hormonal control
  3 recalls10 reports
• MiniMed® 670G MMT-1760K

  Artificial pancreas device system, single hormonal control
  3 recalls3 reports
• MiniMed® 670G MMT-1760KP

  Automated insulin dosing device system, single hormonal control
  3 recalls0 reports
• MiniMed® 670G MMT-1760KM

  Automated insulin dosing device system, single hormonal control
  3 recalls0 reports
• MiniMed® 670G MMT-1760KR

  Automated insulin dosing device system, single hormonal control
  3 recalls0 reports
• MiniMed® 670G MMT-1780KPK

  Automated insulin dosing device system, single hormonal control
  2 recalls0 reports
• MiniMed® 670G MMT-1760KPK

  Automated insulin dosing , threshold suspend
  2 recalls0 reports
• MiniMed® 670G MMT-1780KR

  Automated insulin dosing device system, single hormonal control
  1 recall2 reports
• MiniMed® 670G MMT-1780KP

  Automated insulin dosing device system, single hormonal control
  19 reports

Recent MiniMed 670G adverse event reports

The 15 most recent reports across all models, in the reporter's own words as published by the FDA.

• MalfunctionSep 19, 2025Material Integrity Problem; Material Integrity Problem

  IT WAS REPORTED TO MEDTRONIC MINIMED THAT THE CUSTOMER EXPERIENCED COSMETIC DAMAGE. THE CUSTOMER REPORTED NO ADVERSE EVENT. THE EVENT INVOLVED PRODUCT(S) MMT-1780KPK. TROUBLESHOOTING WAS NOT PERFORMED. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER WILL DISCONTINUE THE USE OF THE PUMP AND REVERT TO A BACKUP PLAN PER HEALTHCARE PROFESSIONAL INSTRUCTIONS. MMT-1780KPK WAS REQUESTED AND CUSTOMER RESPONSE WAS THE DEVICE RETURNED.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 23095113 ↗
• MalfunctionJul 7, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

  IT WAS REPORTED TO MEDTRONIC MINIMED THAT THE CUSTOMER EXPERIENCED HIGH BLOOD GLUCOSE READINGS WHILE FLYING AND WEARING A MASK, AS WELL AS NEEDING ASSISTANCE WITH UPLOADING THEIR PUMP TO CARELINK. THE CUSTOMER REPORTED NO ADVERSE EVENT. THE EVENT INVOLVED PRODUCT(S) MMT-1780KPK AND ACC-7350. TROUBLESHOOTING WAS DECLINED BY THE CUSTOMER. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. NO PRODUCT RETURN IS REQUIRED FOR MMT-1780KPK. NO PRODUCT RETURN IS REQUIRED FOR ACC-7350.

  Patient problems: Hyperglycemia

  MAUDE report 22409686 ↗
• MalfunctionJul 7, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

  IT WAS REPORTED TO MEDTRONIC MINIMED THAT THE CUSTOMER EXPERIENCED HYPERGLYCEMIA AFTER AIR TRAVEL AND ENCOUNTERED SENSOR ISSUES, INCLUDING "SENSOR UPDATING" ALERTS. BLOOD GLUCOSE VALUE AT THE TIME OF THE EVENT WAS 350 MG/DL, ACCOMPANIED BY SYMPTOMS SUCH AS HEADACHE AND THIRST. THE CUSTOMER VISITED EMERGENCY ROOM FOR THE TREATMENT. THE EVENT INVOLVED PRODUCT(S) MMT-1780KL, MMT-7020A, MMT-864A, AND MMT-332A. TROUBLESHOOTING WAS PERFORMED, WHICH INCLUDED EXPLAINING POSSIBLE CAUSES OF SENSOR ALERTS, ADVISING THE CUSTOMER TO MONITOR BLOOD GLUCOSE LEVELS, AND RECOMMENDING CHANGES TO THE INFUSION SET, RESERVOIR, AND INSULIN. THE CUSTOMER DECLINED TO CHECK FOR LEAKS, SITE/INSULIN ISSUES, OR PERFORM THE HIGH PRESSURE TEST BUT CONFIRMED THAT THE CURRENT SET SEEMED TO BE WORKING FINE. THE CUSTOMER WAS ADVISED TO TURN ON AIRPLANE MODE DURING FLIGHTS, MONITOR BLOOD GLUCOSE LEVELS, AND CALL BACK IF ISSUES PERSISTED. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED. NO PRODUCT RETURN IS REQUIRED FOR MMT-1780KL, MMT-7020A, MMT-864A, AND MMT-332A.

  Patient problems: Dehydration; Headache; Hyperglycemia

  MAUDE report 22409635 ↗
• MalfunctionJul 7, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

  IT WAS REPORTED TO MEDTRONIC MINIMED THAT THE CUSTOMER EXPERIENCED LOW BLOOD GLUCOSE LEVELS. THE CUSTOMER ALSO RECEIVED A CALIBRATION NOT ACCEPTED ALERTS AND CHANGE SENSOR ALARMS. THE HYPOGLYCEMIA WAS TREATED WITH FOOD. THE BLOOD GLUCOSE VALUE AT THE TIME OF THE EVENT WAS 67 MG/DL. THE CUSTOMER REPORTED NO ADVERSE EVENT. THE EVENT INVOLVED PRODUCT(S) MMT-7020A AND MMT-1780KPK. TROUBLESHOOTING WAS PARTIALLY PERFORMED. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. NO PRODUCT RETURN IS REQUIRED FOR ANALYSIS MMT-7020A. NO PRODUCT RETURN IS REQUIRED FOR ANALYSIS MMT-1780KPK.

  Patient problems: Hypoglycemia

  MAUDE report 22409630 ↗
• MalfunctionJul 7, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

  IT WAS REPORTED TO MEDTRONIC MINIMED THAT THE CUSTOMER EXPERIENCED HYPERGLYCEMIA. THE CUSTOMER ALSO REPORTED SENSOR UPDATING ALERT AND STATED THAT THE HIGH BLOOD GLUCOSE EVENT OCCURRED DURING THE FLIGHT. THE CUSTOMER WAS TREATED WITH AN INSULIN PUMP. THE EVENT INVOLVED PRODUCT(S) MMT-1780KPK. TROUBLESHOOTING WAS PERFORMED, WHICH INCLUDED EXPLAINING POSSIBLE CAUSES OF SENSOR UPDATING ALERTS, INSPECTING THE SENSOR TO ENSURE IT WAS SECURELY TAPED, AND ADVISING THE CUSTOMER ABOUT SENSOR PLACEMENT AND BEST PRACTICES FOR INSERTION WHILE STANDING UP. THE CUSTOMER DECLINED FURTHER TROUBLESHOOTING, INCLUDING TESTING THE TRANSMITTER OR REVIEWING SITE SELECTION, TAPING, AND CALIBRATION PROTOCOL. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED. NO PRODUCT RETURN IS REQUIRED FOR MMT-1780KPK.

  Patient problems: Hyperglycemia

  MAUDE report 22409609 ↗
• MalfunctionJul 7, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

  IT WAS REPORTED TO MEDTRONIC MINIMED THAT THE CUSTOMER EXPERIENCED LOW BLOOD GLUCOSE LEVELS AFTER FLIGHTS. THE CUSTOMER REPORTED NO ADVERSE EVENT. THE EVENT INVOLVED PRODUCT(S) MMT-1780KPK. TROUBLESHOOTING WAS PERFORMED BUT IT WAS UNKNOWN WHETHER THE INSULIN PUMP WAS UTILIZED WITHIN 48 HOURS OF THE EVENT ALSO, IT WAS UNKNOWN WHETHER THE AUTO MODE FEATURE WAS ACTIVE OR NOT. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE PRODUCT WAS NOT RETURNED FOR ANALYSIS.

  Patient problems: Hypoglycemia

  MAUDE report 22409607 ↗
• MalfunctionJul 7, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

  IT WAS REPORTED TO MEDTRONIC MINIMED THAT THE CUSTOMER EXPERIENCED HYPERGLYCEMIA DURING AIR TRAVEL, WITH BLOOD GLUCOSE VALUES REACHING 300 MG/DL. BLOOD GLUCOSE VALUE AT THE TIME OF THE EVENT WAS 300 MG/DL. THE CUSTOMER WAS TREATED WITH INSULIN PEN. THE EVENT INVOLVED PRODUCT(S) MMT-1780KPK, MMT-332A, AND MMT-943. TROUBLESHOOTING WAS PERFORMED, WHICH INCLUDED VERIFYING PUMP SETTINGS, INSPECTING TUBING AND RESERVOIR FOR LEAKS OR AIR BUBBLES, CHECKING THE INFUSION SET AND INSULIN VIAL, AND REVIEWING AUTO MODE OPERATION AND BOLUS DELIVERY PROCESSES. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED. NO PRODUCT RETURN IS REQUIRED FOR MMT-1780KPK, MMT-332A, AND MMT-943.

  Patient problems: Hyperglycemia

  MAUDE report 22409600 ↗
• MalfunctionJul 7, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

  IT WAS REPORTED TO MEDTRONIC MINIMED THAT THE CUSTOMER EXPERIENCED HYPERGLYCEMIA. THE BLOOD GLUCOSE VALUE AT THE TIME OF THE EVENT WAS 360 MG/DL. THE HYPERGLYCEMIA WAS TREATED WITH AN INSULIN PUMP. THE EVENT INVOLVED PRODUCT(S) MMT-1780KL. TROUBLESHOOTING WAS PERFORMED, AND THE CUSTOMER WAS USING THE INSULIN PUMP WITHIN 48 HOURS OF THE EVENT. ALSO, THE CUSTOMER WAS USING THE AUTO MODE FEATURE WAS ACTIVE OR NOT. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED. NO PRODUCT RETURN IS REQUIRED FOR MMT-1780KL.

  Patient problems: Hyperglycemia

  MAUDE report 22409592 ↗
• MalfunctionJul 7, 2025Excess Flow or Over-Infusion; Excess Flow or Over-Infusion

  IT WAS REPORTED TO MEDTRONIC MINIMED THAT THE CUSTOMER EXPERIENCED OVER-DELIVERY OF INSULIN DURING AIR TRAVEL. THE CUSTOMER REPORTED SEVERE HYPOGLYCEMIA DURING FLIGHTS AND SEVERE HYPERGLYCEMIA POST-FLIGHT. THE EVENT INVOLVED PRODUCT(S) MMT-1780KPK. TROUBLESHOOTING WAS NOT PERFORMED. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. NO PRODUCT RETURN IS REQUIRED FOR MMT-1780KPK.

  Patient problems: Hyperglycemia; Hypoglycemia

  MAUDE report 22409560 ↗
• MalfunctionJul 7, 2025Wireless Communication Problem; Wireless Communication Problem

  IT WAS REPORTED TO MEDTRONIC MINIMED THAT THE CUSTOMER EXPERIENCED A LOW BLOOD GLUCOSE LEVEL AND HEAD PAIN DURING A FLIGHT DESCENT. THE CUSTOMER INQUIRED ABOUT USING AIRPLANE MODE ON THE PUMP DURING FLIGHTS. THE EVENT INVOLVED PRODUCT(S) MMT-1780KPK. TROUBLESHOOTING WAS PERFORMED, AND THE CUSTOMER REPORTED THAT THE PUMP AND GLUCOMETER WERE NOT CONNECTING. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE PRODUCT WAS NOT RETURNED FOR ANALYSIS.

  Patient problems: Hypoglycemia; Pain

  MAUDE report 22409530 ↗
• MalfunctionJul 7, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

  IT WAS REPORTED TO MEDTRONIC MINIMED THAT THE CUSTOMER EXPERIENCED HYPERGLYCEMIA. THE CUSTOMER ALSO REPORTED SENSOR ALERTS WITH CHANGE SENSOR MESSAGES AFTER 5-6 DAYS OF USE DURING THE LAST TWO WEEKS. THE CUSTOMER ATTRIBUTED THE ISSUE TO ELEVATED BLOOD GLUCOSE (BG) LEVELS DURING FLIGHTS AND DIFFICULTY MANAGING DIABETES DUE TO IRREGULAR EATING TIMES. BLOOD GLUCOSE VALUE AT THE TIME OF EVENT WAS 278 MG/DL. THE EVENT INVOLVED PRODUCT(S) MMT-1780K, MMT-7020A. TROUBLESHOOTING WAS PERFORMED, WHICH INCLUDED EXPLAINING THE CHANGE SENSOR ALERT AND POSSIBLE CAUSES, BUT THE CUSTOMER DECLINED FURTHER TROUBLESHOOTING FOR HIGH BLOOD GLUCOSE EVENT. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED. NO PRODUCT RETURN IS REQUIRED FOR MMT-1780K. MMT-7020A WAS RETURNED FOR ANALYSIS.

  Patient problems: Hyperglycemia

  MAUDE report 22409525 ↗
• MalfunctionJul 7, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

  IT WAS REPORTED TO MEDTRONIC MINIMED THAT THE CUSTOMER EXPERIENCED HIGH BLOOD GLUCOSE LEVELS AFTER A FLIGHT. THE CUSTOMER REPORTED NO ADVERSE EVENT. THE EVENT INVOLVED PRODUCT(S) MMT-1780KPK. TROUBLESHOOTING WAS NOT PERFORMED. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE PRODUCT WAS NOT RETURNED FOR ANALYSIS.

  Patient problems: Hyperglycemia

  MAUDE report 22409512 ↗
• MalfunctionJul 7, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

  IT WAS REPORTED TO MEDTRONIC MINIMED THAT THE CUSTOMER EXPERIENCED HYPOGLYCEMIA. THE CUSTOMER ALSO REPORTED THAT THE HYPOGLYCEMIA EVENT OCCURRED DURING THE FLIGHT JOURNEY. BLOOD GLUCOSE VALUE AT THE TIME OF EVENT WAS 70 MG/DL. THE CUSTOMER WAS TREATED WITH CARBOHYDRATE INTAKE. THE EVENT INVOLVED PRODUCT(S) MMT-1780KPK. TROUBLESHOOTING WAS NOT PERFORMED. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED. NO PRODUCT RETURN IS REQUIRED FOR MMT-1780KPK.

  Patient problems: Hypoglycemia

  MAUDE report 22409508 ↗
• MalfunctionJul 7, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

  IT WAS REPORTED TO MEDTRONIC MINIMED THAT THE CUSTOMER EXPERIENCED HYPOGLYCEMIA DURING THE FLIGHT. THE CUSTOMER ALSO REPORTED A CALIBRATION NOT ACCEPTED ALERT. THE BLOOD GLUCOSE VALUE AT THE TIME OF THE EVENT WAS 56 MG/DL. THE LOW BLOOD GLUCOSE WAS TREATED WITH CARB INTAKE. THE EVENT INVOLVED PRODUCT(S) MMT-7020A, MMT-1780KPK. TROUBLESHOOTING WAS PERFORMED. IT WAS UNKNOWN WHETHER THE CUSTOMER WAS USING THE AUTO MODE/SMART GUARD FEATURE AT THE TIME OF THE EVENT. IT WAS UNKNOWN WHETHER THE CUSTOMER WAS USING THE INSULIN PUMP SYSTEM WITHIN 48 HOURS OF THE REPORTED EVENT. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED. MMT-7020A NO PRODUCT RETURN IS REQUIRED FOR ANALYSIS. MMT-1780KPK NO PRODUCT RETURN IS REQUIRED FOR ANALYSIS.

  Patient problems: Hypoglycemia

  MAUDE report 22409502 ↗
• MalfunctionJul 3, 2025Excess Flow or Over-Infusion; Excess Flow or Over-Infusion

  IT WAS REPORTED TO MEDTRONIC MINIMED THAT THE CUSTOMER EXPERIENCED HYPOGLYCEMIA. THE CUSTOMER ALSO REPORTED POSSIBLE OVER-DELIVERY OF INSULIN. THE CUSTOMER ALSO REPORTED DIFFICULTY UPLOADING PUMP DATA TO CARELINK DUE TO A COMMUNICATION ERROR AND REQUESTED ASSISTANCE. THE CUSTOMER EXPERIENCED SYMPTOMS OF ILLNESS AND SEIZURES AT THE TIME OF THE EVENT. THE CUSTOMER WAS TREATED WITH CARBOHYDRATE INTAKE. THE EVENT INVOLVED PRODUCT(S) MMT-1780K, MMT-7333, AND MMT-965. TROUBLESHOOTING WAS PERFORMED, WHICH INCLUDED REVIEWING PUMP PROGRAMMING, INFUSION SET USAGE, AND INSULIN TYPE, AND ADVISING THE CUSTOMER TO AVOID EXPOSURE TO STRONG MAGNETIC FIELDS. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED. MMT-1780K WAS RETURNED FOR ANALYSIS. NO PRODUCT RETURN IS REQUIRED FOR MMT-7333 AND MMT-965.

  Patient problems: Hypoglycemia; Malaise

  MAUDE report 22394390 ↗

Other Medtronic Minimed, Inc. products

• MiniMed 630G23 models · 65,972 reports · 6 recalls
• Paradigm REAL-Time Revel180 models · 49,838 reports · 2 recalls
• MiniMed 530G71 models · 48,745 reports · 1 recall
• MiniMed670G2 models · 28,871 reports · 3 recalls
• MiniMed630G2 models · 6,656 reports · 5 recalls
• MiniMed Reservoir6 models · 4,545 reports
• PARADIGM REAL-time95 models · 2,862 reports · 1 recall
• Guardian Sensor (3)11 models · 2,726 reports